TABLE 3.
Study | No. of clinical isolates or strains | Concn (μg/ml) inhibiting:
|
EC50 range (μg/ml) | |
---|---|---|---|---|
50% of isolates or strains | 80% of isolates or strains | |||
843-043a | 346 | 0.06 | 0.50 | 0.0008 to >3.8 |
843-044a | 398 | 0.04 | 0.35 | 0.0008 to >3.8 |
Pooled | 744 | 0.05 | 0.42 | 0.0008 to >3.8 |
Kaiser et al. (22) | 46 | 0.04 | 0.54 | <0.01 to >1.0 |
ViroPharma (24) | 101b | 0.08 | 0.30 | 0.008 to >4.8 |
Baseline virus isolates.
Prototype HRV strains.